In a network analysis comprising 18 pediatric ACC patients, CDK1, CCNB1, CDC20, and BUB1B were identified as potential biomarkers of pediatric ACC, though not as expressive as in adult cohorts [133], and as potential targets for a therapeutic approach [134]. Here, CDK1 is linked to adrenal cortex carcinoma.